UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 76

Sortiert nach

Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2

PloS one, 2014-04, Vol.9 (4), p.e94892-e94892

2014

Volltextzugriff (PDF)

Humoral and cellular CMV responses in healthy donors; identification of a frequent population of CMV-specific, CD4+ T cells in seronegative donors

PloS one, 2012-02, Vol.7 (2), p.e31420-e31420

2012

Volltextzugriff (PDF)

MHC class II tetramers made from isolated recombinant α and β chains refolded with affinity-tagged peptides

PloS one, 2013, Vol.8 (9), p.e73648-e73648

2013

Volltextzugriff (PDF)

Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome

Critical care (London, England), 2008-01, Vol.12 (3), p.R83-R83

2008

Volltextzugriff (PDF)

Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT)

European journal of haematology, 2001-02, Vol.66 (2), p.73-82

Vindelov, Lars

2001

Volltextzugriff (PDF)

YKL-40 in allogeneic hematopoietic cell transplantation after acute myeloid leukemia and myelodysplastic syndrome

Bone marrow transplantation (Basingstoke), 2016-07, Vol.51 (12), p.1556-1560

2016

Volltextzugriff (PDF)

Generation of EBV-specific CTLs suitable for adoptive immunotherapy of EBV-associated lymphoproliferative disease following allogeneic transplantation

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2002-02, Vol.110 (2), p.148-157

2002

Volltextzugriff (PDF)

The Prognostic Value of YKL-40 in Allogeneic Hematopoietic Cell Transplantation

Blood, 2014-12, Vol.124 (21), p.1176-1176

2014

Volltextzugriff (PDF)

Correction: MHC Class II Tetramers Made from Isolated Recombinant α and β Chains Refolded with Affinity-Tagged Peptides

PloS one, 2013-12, Vol.8 (12)

2013

Volltextzugriff (PDF)

Correction: MHC Class II Tetramers Made from Isolated Recombinant α and β Chains Refolded with Affinity-Tagged Peptides

PloS one, 2013-09, Vol.8 (9)

2013

Volltextzugriff (PDF)

Identification and HLA-tetramer-validation of human [CD4.sup.+] and [CD8.sup.+] T cell responses against HCMV proteins IE1 and IE2

PloS one, 2014-04, Vol.9 (4)

2014

Volltextzugriff (PDF)

Impact of Postremission Consolidation Chemotherapy On Outcome After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for AML in First Complete Remission (CR1): A Report From the Acute Leukemia Working Party of EBMT

Blood, 2012-11, Vol.120 (21), p.3098-3098

2012

Volltextzugriff (PDF)

Graft rejection after hematopoietic cell transplantation with nonmyeloablative conditioning

American journal of hematology, 2008-07, Vol.83 (7), p.563-569

2008

Volltextzugriff (PDF)

Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4'-(9-acridylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage

Cancer research (Chicago, Ill.), 1990-06, Vol.50 (11), p.3311-3316

1990

Volltextzugriff (PDF)

Impact of Chronic Graft-Versus-Host disease (GVHD) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) As Treatment for Acute Myeloid Leukemia (AML): A Survey From the Acute Leukemia Working Party of the EBMT

Blood, 2011-11, Vol.118 (21), p.321-321

2011

Volltextzugriff (PDF)

Antagonistic effect of aclarubicin on daunorubicin-induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II

Cancer research (Chicago, Ill.), 1991-10, Vol.51 (19), p.5093-5099

1991

Volltextzugriff (PDF)

Association of HMGB1 Polymorphisms with Outcome After Allogeneic Hematopoietic Cell Transplantation

Blood, 2009-11, Vol.114 (22), p.2260-2260

2009

Volltextzugriff (PDF)

Genetic Variation in AKAP13 Is Associated with Increased Risk of Relapse after Allogeneic Hematopoietic Cell Transplantation Following Non-Myeloablative Conditioning

Blood, 2008-11, Vol.112 (11), p.3257-3257

2008

Volltextzugriff (PDF)

The PTPN22 1858C/T Polymorphism Is Associated with the Development of Grade 3 to 4 Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation Following Nonmyeloablative Conditioning

Blood, 2007-11, Vol.110 (11), p.1969-1969

2007

Volltextzugriff (PDF)

A Randomized Trial Comparing Busulfan With Total Body Irradiation as Conditioning in Allogeneic Marrow Transplant Recipients With Leukemia: A Report From the Nordic Bone Marrow Transplantation Group

Blood, 1994-05, Vol.83 (9), p.2723-2730

1994

Volltextzugriff (PDF)

Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice

Cancer research (Chicago, Ill.), 1989-03, Vol.49 (6), p.1515-1520

1989

Volltextzugriff (PDF)

Limiting dilution analysis of interleukin-2 producing helper T-cell frequencies as a tool in allogeneic hematopoietic cell transplantation

Transplantation, 2005-09, Vol.80 (5), p.573

2005

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(67)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(34)
Science & Technology
(27)
Life Sciences & Biomedicine
(24)
Biological And Medical Sciences
(21)
Medical Sciences
(20)
Animals
(16)
Flow Cytometry
(15)
Mice
(13)
Antineoplastic Agents
(12)
Pharmacology. Drug Treatments
(12)
Carcinoma, Small Cell - Drug Therapy
(10)
Lung Neoplasms - Drug Therapy
(10)
General Aspects
(9)
Mice, Nude
(9)
Hematology
(8)
Immunology
(8)
Neoplasm Transplantation
(8)
Oncology
(8)
Dose-Response Relationship, Drug
(6)
Tumor Cells, Cultured - Drug Effects
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2

Humoral and cellular CMV responses in healthy donors; identification of a frequent population of CMV-specific, CD4+ T cells in seronegative donors

MHC class II tetramers made from isolated recombinant α and β chains refolded with affinity-tagged peptides

Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome

Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT)

YKL-40 in allogeneic hematopoietic cell transplantation after acute myeloid leukemia and myelodysplastic syndrome

Generation of EBV-specific CTLs suitable for adoptive immunotherapy of EBV-associated lymphoproliferative disease following allogeneic transplantation

The Prognostic Value of YKL-40 in Allogeneic Hematopoietic Cell Transplantation

Correction: MHC Class II Tetramers Made from Isolated Recombinant α and β Chains Refolded with Affinity-Tagged Peptides

Correction: MHC Class II Tetramers Made from Isolated Recombinant α and β Chains Refolded with Affinity-Tagged Peptides

Identification and HLA-tetramer-validation of human [CD4.sup.+] and [CD8.sup.+] T cell responses against HCMV proteins IE1 and IE2

Impact of Postremission Consolidation Chemotherapy On Outcome After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for AML in First Complete Remission (CR1): A Report From the Acute Leukemia Working Party of EBMT

Graft rejection after hematopoietic cell transplantation with nonmyeloablative conditioning

Equivalent Outcome Between Older Siblings and Unrelated Donors After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Patients Older Than 50 Years with Acute Myeloid Leukemia in First Complete Remission: A Report From the ALWP of EBMT

Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4'-(9-acridylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage

Impact of Chronic Graft-Versus-Host disease (GVHD) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) As Treatment for Acute Myeloid Leukemia (AML): A Survey From the Acute Leukemia Working Party of the EBMT

Antagonistic effect of aclarubicin on daunorubicin-induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II

Association of HMGB1 Polymorphisms with Outcome After Allogeneic Hematopoietic Cell Transplantation

Genetic Variation in AKAP13 Is Associated with Increased Risk of Relapse after Allogeneic Hematopoietic Cell Transplantation Following Non-Myeloablative Conditioning

The PTPN22 1858C/T Polymorphism Is Associated with the Development of Grade 3 to 4 Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation Following Nonmyeloablative Conditioning

A Randomized Trial Comparing Busulfan With Total Body Irradiation as Conditioning in Allogeneic Marrow Transplant Recipients With Leukemia: A Report From the Nordic Bone Marrow Transplantation Group

Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice

Impacts of Cytogenetic Abnormalities and Prior Alemtuzumab on Outcomes of Patients (pts) with High-Risk Chronic Lymphocytic Leukemia (CLL) Given Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT)

Limiting dilution analysis of interleukin-2 producing helper T-cell frequencies as a tool in allogeneic hematopoietic cell transplantation

Aktive Filter

Suchergebnisse filtern